Stimulation of TRAF6/TAK1 degradation and inhibition of JNK/AP-1 signalling by ginsenoside Rg3 attenuates hepatitis B virus replication

Rg3 showed anti-hepatitis B and anti-inflammatory activities via the inhibition of TRAF6/TAK1 and JNK/AP-1 signalling events in HepG2.2.15 cells that constitutively express HBsAg, HBeAg, and viral particles.